Tokai Valve Registry

Tokai Valve Registry - Tokai Valve Registry

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036671

Enrollment

500

Registered

2019-05-08

Start date

2016-11-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Valvular heart disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -Patients with age of over 20 -Patients with more than moderate aortic regurgitation(vena contracta 3-6mm, effective regurgitant orifice area>0.1cm2, regurgitant volume>30ml) -Patients with more than moderate aortic stenosis(peak velocity>3m/sec, mean pressure gradient>20mmHg) -Patients with more than moderate mitral regurgitation(vena contracta 3-6mm, effective regurgitant orifice area>0.2cm2, regurgitant volume>30ml) -Patients with more than moderate mitral stenosis(mitral valve area<2cm2) -Patients with more than moderate tricuspid regurgitation(vena contracta 3-6mm) -Patients who had sufficient informed consent and provided written informed consent

Exclusion criteria

Exclusion criteria: -Patients with age of below 20

Design outcomes

Primary

Measure	Time frame
All cause mortality and hospitalization due to heart failure (30 days, 1 year, and annually to 5 years after treatment)	—

Secondary

Measure	Time frame
heart failure functional class, exercise capacity, cardiac function parameters	—

Countries

Japan

Contacts

Public ContactYohei Ohno

Tokai University Hospital Department of Cardiology

y-ohno@umin.ac.jp0463931121

Outcome results